Seamount Financial Group
EW icon

Seamount Financial Group’s Edwards Lifesciences EW Stock Holding History

Seamount Financial Group’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$286K Hold
3,312
– – 0.11% 115
2026
Q2 		$300K Hold
3,312
– – 0.12% 113
2026
Q1 		$265K Hold
3,312
– – 0.12% 116
2025
Q4 		$282K Hold
3,312
– – 0.13% 116
2025
Q3 		$258K Hold
3,312
– – 0.12% 116
2025
Q2 		$259K Buy
+3,312
New +$247K 0.13% 112

Other funds holding EW

Ninety One (UK)
Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Birch Hill Investment Advisors
Birch Hill Investment Advisors Boston, Massachusetts $2.43B AUM 15.45% 1-Year Est. Return
Virginia Retirement Systems
Virginia Retirement Systems Richmond, Virginia $16.3B AUM 35.33% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Seilern Investment Management
Seilern Investment Management London, United Kingdom $771M AUM 2.59% 1-Year Est. Return
Ninety One North America
Ninety One North America New York $2.13B AUM 8.8% 1-Year Est. Return

Seamount Financial Group's EW Position: Q3 2026 in Review

Seamount Financial Group held its Edwards Lifesciences (EW) position steady in Q3 2026 at 3,312 shares worth $286K. The position accounts for 0.11% of the portfolio, ranked #115.

Seamount Financial Group first reported a position in EW in Q2 2025 and has held it in 6 quarters since. The position peaked at $300K in Q2 2026. 492 funds tracked by Wall St. Rank hold EW as of Q3 2026.

  • Seamount Financial Group held 3,312 shares of Edwards Lifesciences worth $286K as of Q3 2026.
  • Seamount Financial Group left its Edwards Lifesciences share count unchanged in Q3 2026.
  • Edwards Lifesciences made up 0.11% of Seamount Financial Group's portfolio in Q3 2026, its #115 holding.
  • Seamount Financial Group first reported a position in Edwards Lifesciences in Q2 2025 and has held it in 6 quarters since.
  • Seamount Financial Group's Edwards Lifesciences position peaked at $300K in Q2 2026.
  • 492 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.

Based on Seamount Financial Group's 13F filing for Q3 2026, filed 21 Oct 2026.